Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Modeling Zika virus transmission from mother to child using uterine mini-organs
As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...
Manuka Honey: A New Tool in the Battle Against Antibiotic Resistance?
Since settlers brought honeybees to New Zealand, inhabitants have utilized honey produced from the native...
Finding a Cure for Batten Disease
In March of this year, both of our daughters, Charlotte and Gwenyth, were diagnosed with Late Infantile...